The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(1-(3-amino-4-chloroisoxazolo[5,4-c]pyridin-7-yl)pyrrolidin-3-yl)-2-chloro-4-(pyrimidin-2-yl)benzamide ID: ALA4103170
PubChem CID: 137658233
Max Phase: Preclinical
Molecular Formula: C21H17Cl2N7O2
Molecular Weight: 470.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1noc2c(N3CC[C@@H](NC(=O)c4ccc(-c5ncccn5)cc4Cl)C3)ncc(Cl)c12
Standard InChI: InChI=1S/C21H17Cl2N7O2/c22-14-8-11(19-25-5-1-6-26-19)2-3-13(14)21(31)28-12-4-7-30(10-12)20-17-16(15(23)9-27-20)18(24)29-32-17/h1-3,5-6,8-9,12H,4,7,10H2,(H2,24,29)(H,28,31)/t12-/m1/s1
Standard InChI Key: KEBDKOMVVMMYGA-GFCCVEGCSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
35.3318 -22.6791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3306 -23.4986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0387 -23.9076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7483 -23.4981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7455 -22.6755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0369 -22.2702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6240 -22.2707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6238 -21.4535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.9164 -22.6794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.2086 -22.2710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1225 -21.4594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3232 -21.2897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9147 -21.9975 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4617 -22.6046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1040 -22.0849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6239 -21.4222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8120 -21.5075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4791 -22.2548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7745 -22.8290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9607 -22.9215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7972 -23.7241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5100 -24.1276 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1139 -23.5744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0535 -24.0627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.0345 -21.4530 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
28.6662 -22.3390 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
37.4532 -23.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4531 -24.7232 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.1606 -25.1306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8687 -24.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8648 -23.8994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1567 -23.4957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 2 0
7 9 1 0
10 9 1 1
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 10 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 20 1 0
19 15 1 0
13 15 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 1 0
21 24 1 0
6 25 1 0
18 26 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
4 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 470.32Molecular Weight (Monoisotopic): 469.0821AlogP: 3.58#Rotatable Bonds: 4Polar Surface Area: 123.06Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.22CX Basic pKa: 1.65CX LogP: 3.29CX LogD: 3.29Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.46Np Likeness Score: -1.76
References 1. Sakurada I, Endo T, Hikita K, Hirabayashi T, Hosaka Y, Kato Y, Maeda Y, Matsumoto S, Mizuno T, Nagasue H, Nishimura T, Shimada S, Shinozaki M, Taguchi K, Takeuchi K, Yokoyama T, Hruza A, Reichert P, Zhang T, Wood HB, Nakao K, Furusako S.. (2017) Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors., 27 (11): [PMID:28408226 ] [10.1016/j.bmcl.2017.03.002 ]